Priming primary care physicians to treat osteoporosis after a fragility fracture: An integrated multidisciplinary approach

Journal of Rheumatology

Volumn 40, Issue 5, 2013, Pages 703-711

  Roux, Sophie ^a   Beaulieu, Michèle ^b   Beaulieu, Marie Claude ^a   Cabana, François ^a   Boire, Gilles ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b Merck Canada Inc   (Canada)

Author keywords

Family physicians; Fractures; Osteoporosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; DENOSUMAB; PARATHYROID HORMONE[1-34]; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; CONTROLLED STUDY; FEMALE; FRAGILITY FRACTURE; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HEALTH EDUCATION; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; INTENSIVE INTERVENTION; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MINIMAL INTERVENTION; MOTIVATION; OSTEOPOROSIS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

FAMILY PHYSICIANS; FRACTURES; OSTEOPOROSIS;

AGED; DISEASE MANAGEMENT; FEMALE; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PATIENT EDUCATION AS TOPIC; PRIMARY HEALTH CARE; PROFESSIONAL PRACTICE;

EID: 84876940608     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120908     Document Type: Article

References (42)

1. Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004;35:375-82. (Pubitemid 38953182)
2. Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: Summary. CMAJ 2010;182:1864-73.
3. Wustrack R, Seeman E, Bucci-Rechtweg C, Burch S, Palermo L, Black DM. Predictors of new and severe vertebral fractures: Results from the HORIZON Pivotal Fracture Trial. Osteoporos Int 2012;23:53-8.
4. Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 2009;301:513-21.
5. Compston JE, Seeman E. Compliance with osteoporosis therapy is the weakest link. Lancet 2006;368:973-4. (Pubitemid 44353676)
6. Bessette L, Ste-Marie LG, Jean S, Davison KS, Beaulieu M, Baranci M, et al. The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int 2008;19:79-86. (Pubitemid 350198056)
7. Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD. Fragility fractures and the osteoporosis care gap: An international phenomenon. Semin Arthritis Rheum 2006;35:293-305.
8. McLellan AR, Gallacher SJ, Fraser M, McQuillian C. The fracture liaison service: Success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 2003;14:1028-34. (Pubitemid 40824270)
9. Sale JE, Beaton D, Posen J, Elliot-Gibson V, Bogoch E. Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients. Osteoporos Int 2011;22:2067-82.
10. Malochet-Guinamand S, Chalard N, Billault C, Breuil N, Ristori JM, Schmidt J. Osteoporosis treatment in postmenopausal women after peripheral fractures: Impact of information to general practitioners. Joint Bone Spine 2005;72:562-6. (Pubitemid 41821417)
11. Bessette L, Davison KS, Jean S, Roy S, Ste-Marie LG, Brown JP. The impact of two educational interventions on osteoporosis diagnosis and treatment after fragility fracture: A population-based randomized controlled trial. Osteoporos Int 2011;22:2963-72.
12. Hawker G, Ridout R, Ricupero M, Jaglal S, Bogoch E. The impact of a simple fracture clinic intervention in improving the diagnosis and treatment of osteoporosis in fragility fracture patients. Osteoporos Int 2003;14:171-8. (Pubitemid 40824235)
13. Montori VM, Shah ND, Pencille LJ, Branda ME, Van Houten HK, Swiglo BA, et al. Use of a decision aid to improve treatment decisions in osteoporosis: The osteoporosis choice randomized trial. Am J Med 2011;124:549-56.
14. Kreiger N, Tenenhouse A, Joseph L, Mackenzie T, Poliquin S, Brown J, et al. The Canadian Multicentre Osteoroposis Study (CaMos): Background, rationale, methods. Can J Aging 1999;18:376-87.
15. Leslie WD, Schousboe JT. A review of osteoporosis diagnosis and treatment options in new and recently updated guidelines on case finding around the world. Curr Osteoporos Rep 2011;9:129-40.
16. Liss DT, Chubak J, Anderson ML, Saunders KW, Tuzzio L, Reid RJ. Patient-reported care coordination: Associations with primary care continuity and specialty care use. Ann Fam Med 2011;9:323-9.
17. O'Malley AS, Reschovsky JD. Referral and consultation communication between primary care and specialist physicians: Finding common ground. Arch Intern Med 2011;171:56-65.
18. Cranney A, Lam M, Ruhland L, Brison R, Godwin M, Harrison MM, et al. A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: A cluster randomized trial. Osteoporos Int 2008;19:1733-40.
19. Davis JC, Guy P, Ashe MC, Liu-Ambrose T, Khan K. HipWatch: osteoporosis investigation and treatment after a hip fracture: A 6-month randomized controlled trial. J Gerontol A Biol Sci Med Sci 2007;62:888-91. (Pubitemid 350131674)
20. Majumdar SR, Johnson JA, Bellerose D, McAlister FA, Russell AS, Hanley DA, et al. Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: Randomized controlled pilot study. Osteoporos Int 2011;22:223-30.
21. Leslie WD, LaBine L, Klassen P, Dreilich D, Caetano PA. Closing the gap in postfracture care at the population level: A randomized controlled trial. CMAJ 2012;184:290-6.
22. Cook PF, Emiliozzi S, McCabe MM. Telephone counseling to improve osteoporosis treatment adherence: An effectiveness study in community practice settings. Am J Med Qual 2007;22:445-56.
23. Solomon DH, Gleeson T, Iversen M, Avorn J, Brookhart MA, Lii J, et al. A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: Design of the OPTIMA trial. Osteoporos Int 2010;21:137-44.
24. Boudou L, Gerbay B, Chopin F, Ollagnier E, Collet P, Thomas T. Management of osteoporosis in fracture liaison service associated with long-term adherence to treatment. Osteoporos Int 2011;22:2099-106.
25. Hodsman AB, Leslie WD, Tsang JF, Gamble GD. 10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: An analysis from the Manitoba Bone Density Program. Arch Intern Med 2008;168:2261-7.
26. Pritchard JM, Giangregorio LM, Ioannidis G, Papaioannou A, Adachi JD, Leslie WD. Ankle fractures do not predict osteoporotic fractures in women with or without diabetes. Osteoporos Int 2012;23:957-62.
27. Eastell R, Reid DM, Compston J, Cooper C, Fogelman I, Francis RM, et al. Secondary prevention of osteoporosis: When should a non-vertebral fracture be a trigger for action? QJM 2001;94:575-97. (Pubitemid 33100207)
28. Nevitt MC, Cummings SR, Stone KL, Palermo L, Black DM, Bauer DC, et al. Risk factors for a first-incident radiographic vertebral fracture in women > or = 65 years of age: The study of osteoporotic fractures. J Bone Miner Res 2005;20:131-40. (Pubitemid 41716228)
29. Sornay-Rendu E, Munoz F, Garnero P, Duboeuf F, Delmas PD. Identification of osteopenic women at high risk of fracture: The OFELY study. J Bone Miner Res 2005;20:1813-9. (Pubitemid 41361882)
30. Wasnich RD, Davis JW, Ross PD. Spine fracture risk is predicted by non-spine fractures. Osteoporos Int 1994;4:1-5. (Pubitemid 24034438)
31. Greenfield DM, Eastell R. Risk factors for ankle fracture. Osteoporos Int 2001;12:97-103. (Pubitemid 32244661)
32. Seeley DG, Kelsey J, Jergas M, Nevitt MC. Predictors of ankle and foot fractures in older women. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1996;11:1347-55. (Pubitemid 26282536)
33. Mackey DC, Lui LY, Cawthon PM, Bauer DC, Nevitt MC, Cauley JA, et al. High-trauma fractures and low bone mineral density in older women and men. JAMA 2007;298:2381-8. (Pubitemid 350190779)
34. Stein EM, Liu XS, Nickolas TL, Cohen A, Thomas V, McMahon DJ, et al. Abnormal microarchitecture and stiffness in postmenopausal women with ankle fractures. J Clin Endocrinol Metab 2011;96:2041-8.
35. Gehlbach S, Saag KG, Adachi JD, Hooven FH, Flahive J, Boonen S, et al. Previous fractures at multiple sites increase the risk for subsequent fractures: The Global Longitudinal Study of Osteoporosis in Women. J Bone Miner Res 2012;27:645-53.
36. Taylor AJ, Gary LC, Arora T, Becker DJ, Curtis JR, Kilgore ML, et al. Clinical and demographic factors associated with fractures among older Americans. Osteoporos Int 2011;22:1263-74.
37. Center JR, Bliuc D, Nguyen TV, Eisman JA. Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 2007;297:387-94. (Pubitemid 46155800)
38. Sanders KM, Nicholson GC, Watts JJ, Pasco JA, Henry MJ, Kotowicz MA, et al. Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost-effective? Bone 2006;38:694-700.
39. Kanis JA, Barton IP, Johnell O. Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int 2005;16:475-82.
40. Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 2007;357:1799-809. (Pubitemid 350044800)
41. Donaldson M, Palermo L, Ensrud K, Hochberg M, Schousboe J, Cummings S. Effect of alendronate for reducing fracture by FRAX score and femoral neck BMD: The fracture intervention trial. J Bone Miner Res 2012;27:1804-10.
42. Ryder KM, Cummings SR, Palermo L, Satterfield S, Bauer DC, Feldstein AC, et al. Does a history of non-vertebral fracture identify women without osteoporosis for treatment? J Gen Intern Med 2008;23:1177-81.